menu
close
Toll-Free 1-866-625-9854

Alevian Duo (Pinaverium Bromide, Dimethicone)

Active Ingredient: Pinaverium Bromide, Dimethicone
Dosage: 100 mg/300 mg
Route of Administration: Oral
Dosage Form: Soft gel capsules
Quantity per package: 32
Availability: Out of stock

Alevian Duo is a drug with a triple mechanism of action (antispasmodic, regulator of intestinal and antiflatulent transit) indicated for the treatment of irritable bowel syndrome characterized by abdominal pain or discomfort (visceral hyperalgesia and allodynia) associated with disorders in frequency or consistency of bowel movement in any of its variants (predominant constipation, predominant diarrhea or alternating constipation-diarrhea), irritable bowel, nervous colitis. Alevian Duo also treats nonspecific intestinal dysfunctions of intestinal motility and other functional conditions associated with meteorism such as functional abdominal distension.

Indications

Alevian Duo is comprehensive treatment with triple mechanism of action (antispasmodic, intestinal transit regulator and antiflatulent) indicated in Irritable Bowel Syndrome (IBS) characterized by abdominal pain or discomfort (visceral hyperalgesia and allodynia) associated with disorders in frequency or consistency of intestinal evacuation in any of its variants (predominant constipation, predominant diarrhea or alternating constipation-diarrhea), irritable bowel, nervous colitis, functional collopathy. It is also applied for nonspecific intestinal dysfunctions of intestinal motility and other functional conditions associated with meteorism such as functional abdominal distention.

Dosage and mode of application

A dose regimen: 1 capsule of Alevian Duo twice a day; 10 to 15 minutes before breakfast and lunch. Some severe or difficult-to-control cases may require a dose increase to 1 Alevian Duo capsule 3 times a day. Patients with Irritable Bowel Syndrome have altered gastrointestinal motility regulatory mechanisms in the presence of lipid components of the diet. This results in a state of hypersensitivity and dysfunction in the propulsion of intraluminal gas, so it is advisable to instruct the patient on the advantages of restricting the consumption of dietary fat to no more than 20% of the daily dietary composition. The convenient size of capsules is designed to facilitate the swallowing process in practically any type of patient (e.g. adolescents and elderly patients). It is applied orally.

See also  Panclasa Solution (Phloroglucinol)

Contraindications

Hypersensitivity to the drug components.

Side effects

Allergic reactions.

Interactions

No clinical data recorded.